SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005687
Filing Date
2014-11-14
Accepted
2014-11-13 21:01:35
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20140930.htm 10-Q 1260301
2 EX-31.1 cala-ex311_201409306.htm EX-31.1 12949
3 EX-31.2 cala-ex312_201409307.htm EX-31.2 12912
4 EX-32.1 cala-ex321_201409308.htm EX-32.1 6274
5 EX-32.2 cala-ex322_201409309.htm EX-32.2 6481
  Complete submission text file 0001564590-14-005687.txt   4039109

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cala-20140930.xml EX-101.INS 456953
7 XBRL TAXONOMY EXTENSION SCHEMA cala-20140930.xsd EX-101.SCH 24431
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20140930_cal.xml EX-101.CAL 22426
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20140930_def.xml EX-101.DEF 75045
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20140930_lab.xml EX-101.LAB 208448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20140930_pre.xml EX-101.PRE 168831
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 141220143
SIC: 2834 Pharmaceutical Preparations